Record linkage for postmarketing surveillance.
作者信息
Faich G A
出版信息
Clin Pharmacol Ther. 1989 Oct;46(4):479-80. doi: 10.1038/clpt.1989.169.
PMID:2791451
Abstract
摘要
相似文献
1
Record linkage for postmarketing surveillance.
Clin Pharmacol Ther. 1989 Oct;46(4):479-80. doi: 10.1038/clpt.1989.169.
2
The role of automated record linkage in the postmarketing surveillance of drug safety: a critique.
Clin Pharmacol Ther. 1989 Oct;46(4):371-86. doi: 10.1038/clpt.1989.154.
3
Uninformed criticism of automated record linkage.
Clin Pharmacol Ther. 1989 Oct;46(4):478-9. doi: 10.1038/clpt.1989.168.
4
Automated record linkage: a response to the commentary and letters to the editor.
Clin Pharmacol Ther. 1989 Oct;46(4):395-8. doi: 10.1038/clpt.1989.157.
5
The future of automated record linkage for postmarketing surveillance: a response to Shapiro.
Clin Pharmacol Ther. 1989 Oct;46(4):387-9. doi: 10.1038/clpt.1989.155.
6
Pharmacoepidemiology: the lessons learned; the challenges ahead.
Clin Pharmacol Ther. 1989 Oct;46(4):480. doi: 10.1038/clpt.1989.170.
7
The role of record linkage in post-marketing drug surveillance.
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):77S-82S. doi: 10.1111/j.1365-2125.1986.tb02987.x.
8
Record linkage studies for postmarketing drug surveillance: data quality and validity considerations.
Drug Intell Clin Pharm. 1988 Feb;22(2):157-61. doi: 10.1177/106002808802200216.
9
Fulfilling the Promise of Unique Device Identifiers.
Ann Intern Med. 2018 Aug 7;169(3):183-185. doi: 10.7326/M18-0526. Epub 2018 Jun 5.
10
Postmarketing drug surveillance by record linkage in Tayside.
J Epidemiol Community Health. 1984 Sep;38(3):226-31. doi: 10.1136/jech.38.3.226.
Zotero 插件